Evidence map›Paper›PMID 41690250›Full record

ReviewEBioMedicine2026

Sepsis modelling: current approaches and organ-on-chip perspectives.

Mariana J Silva, Gustavo W Fehrenbach, Robert Pogue, Patrick Murray, Emanuele Rezoagli, John G Laffey, Emma J Murphy

Abstract readReview
In one paragraph

Review in EBioMedicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mariana J SilvaBioengineering (Organ-on-Chip) Research Group, Centre for Applied Bioscience Research, Moylish Campus, Technological University of the Shannon, Limerick, Co. Limerick, V94 EC5T, Ireland; PRISM Research Institute, Department of Engineering, Athlone Campus, Technological University of the Shannon, Athlone, Co. Westmeath, N37 HD68, Ireland; Programa de Ciências Genômicas e Biotecnologia, Universidade Católica de Brasília, 71966-700, Brasilia, Brazil.
Gustavo W FehrenbachBioengineering (Organ-on-Chip) Research Group, Centre for Applied Bioscience Research, Moylish Campus, Technological University of the Shannon, Limerick, Co. Limerick, V94 EC5T, Ireland; PRISM Research Institute, Department of Engineering, Athlone Campus, Technological University of the Shannon, Athlone, Co. Westmeath, N37 HD68, Ireland.
Robert PoguePrograma de Ciências Genômicas e Biotecnologia, Universidade Católica de Brasília, 71966-700, Brasilia, Brazil; Programa de Biotecnologia, Universidade Católica Dom Bosco, 79117-900, Campo Grande, Brazil.
Patrick MurrayLIFE Research Institute, Moylish Campus, Technological University of the Shannon, Limerick, Co. Limerick, V94 EC5T, Ireland.
Emanuele RezoagliSchool of Medicine and Surgery, University of Milano-Bicocca, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.
John G LaffeyAnaesthesia and Intensive Care Medicine, School of Medicine, Regenerative Medicine Institute at CÚRAM Research Ireland Centre for Medical Devices, University of Galway, H91 TK33, Ireland.
Emma J MurphyBioengineering (Organ-on-Chip) Research Group, Centre for Applied Bioscience Research, Moylish Campus, Technological University of the Shannon, Limerick, Co. Limerick, V94 EC5T, Ireland; PRISM Research Institute, Department of Engineering, Athlone Campus, Technological University of the Shannon, Athlone, Co. Westmeath, N37 HD68, Ireland. Electronic address: emma.murphy@tus.ie.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sepsis is a complex life-threatening condition involving immune dysregulation, endothelial dysfunction, and multi-organ failure. To investigate molecular and systemic processes driving disease progression, in vitro, in vivo, and ex vivo experimental methods have been developed. While these systems have advanced understanding of immune activation, cytokine signalling, and organ injury, differences in complexity, reproducibility, and alignment with human pathophysiology have limited the translation of many promising preclinical findings into clinical success. This review examines current literature on sepsis systems, evaluating them in terms of biological complexity, reproducibility, ethical constraints, and clinical applicability. In parallel, it discusses the potential use of microfluidic technology, particularly organ-on-chip, in replicating human physiology and capturing key features of sepsis. By comparing conventional and advanced systems, this review outlines challenges in sepsis research and identifies key directions for a more integrated approach to sepsis modelling, aiming to improve translational outcomes and therapeutic discovery. We aim to provide a structured basis for comparing models when selecting approaches for a given question or candidate therapy.

Indexed as

Lab-On-A-Chip DevicesModels, BiologicalSepsisAnimalsDisease Models, AnimalHumansMicrophysiological SystemsExperimental modelsMicrofluidic systemsOrgan-on-chipSepsisTranslational relevance

Identifiers

PMID41690250
PMCPMC12925287

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.